Lung cancer

Abstract: Yttrium-90 selective internal radiation therapy (SIRT) is a treatment modality used for unresectable hepatic neoplasm, typically from primary hepatic malignancy such as hepatocellular carcinoma or colorectal and neuroendocrine metastases. Although extensive literature exists about SIRT… Read More
ViziShot FLEX 19G is the largest available EBUS-TBNA needle, potentially enabling physicians to provide more targeted therapy for lung cancer patientsCENTER VALLEY, Pa., May 12, 2016 /PRNewswire/ -- Olympus, a global technology leader in designing and delivering innovative solutions for medical and… Read More
London 06 May 2016Builds on BTG’s leadership in Interventional Oncology, expanding franchise into attractive and complementary ablation marketGalil Medical is a leader in cryoablation of kidney cancer with significant pipeline opportunities including lung cancerLondon, UK, 06 May 2016: BTG plc, the… Read More
SACRAMENTO, California, March 4, 2016 /PRNewswire/ --New radiosurgery system enables unprecedented precision in the frameless treatment of brain tumors Elekta, a leading supplier of advanced and innovative radiation oncology and neurosurgery systems, today announced that its Leksell Gamma Knife… Read More
Arschang Valipour, MD, is a chest physician and intensivist at the Otto-Wagner-Spital Department of Respiratory and Critical Care Medicine in Vienna, Austria, as well as associate professor at Medical University of Vienna. He began using the InterVapor vapor ablation system (Uptake Medical) in 2009… Read More
 October 12, 2015 09:15 AM Eastern Daylight TimeTUSTIN, Calif.--(BUSINESS WIRE)--Medical technology innovator Uptake Medical announced today that clinicians have successfully performed the first-ever regional lung cancer tumor ablation with the company’s InterVapor Targeted Vapor Therapy system.“… Read More
Abstract: Surgery is still the most commonly used treatment for early-stage non-small cell lung cancer (NSCLC). However, many patients with NSCLC have significant comorbidities and are not surgical candidates. Radiation therapy has traditionally been the treatment option for these patients. The… Read More
SHANGHAI, China and PALO ALTO, Calif., September 28, 2015 /GlobeNewswire/ -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”), a biomedicine firm engaged in the development of effective stem cell therapies for degenerative diseases and immunotherapies for cancer, today… Read More
San Francisco CyberKnife treatment center to offer radiation therapy for Northern California patientsJune 16, 2015 08:00 AM Eastern Daylight Time: NEWPORT BEACH, Calif. & SAN FRANCISCO--(BUSINESS WIRE)--Alliance Oncology, a division of Alliance HealthCare Services, Inc., a leading national… Read More
First randomized clinical trial comparing the two therapies suggests that the non-invasive SABR treatment should be considered an alternative to surgery, especially for elderly patients and those with comorbiditiesMay 13, 2015 - Newswise — HOUSTON – Patients with operable stage I non-small cell… Read More